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Abstract
The SWI/SNF chromatin remodeling complex is highly conserved from yeast to human and 
aberrant SWI/SNF complexes contribute to human disease. The Snf5/SMARCB1/INI1 subunit of 
SWI/SNF is a tumor supressor frequently lost in pediatric rhabdoid cancers. We examined the 
effects of Snf5 loss on the composition, nucleosome binding, recruitment and remodeling 
activities of yeast SWI/SNF. The Snf5 subunit is shown by crosslinking-mass spectrometry (CX-
MS) and subunit deletion analysis to interact with the ATPase domain of Snf2 and to form a 
submodule consisting of Snf5, Swp82 and Taf14. Snf5 promotes binding of the Snf2 ATPase 
domain to nucleosomal DNA and enhances the catalytic and nucleosome remodeling activities of 
SWI/SNF. Snf5 is also required for SWI/SNF recruitment by acidic transcription factors. RNA-seq 
analysis suggests both the recruitment and remodeling functions of Snf5 are required in vivo for 
SWI/SNF regulation of gene expression. Thus, loss of SNF5 alters the structure and function of 
SWI/SNF.
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Mutation of SWI/SNF chromatin remodeling complex subunits contributes to cancer and 
neurological disorders. Sen et al. report that loss of the Snf5 subunit alters the architecture and 
function of SWI/SNF in a yeast model system. These findings may reflect changes that occur in 
pediatric rhabdoid tumors with mutated Snf5.
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Introduction
The SWI/SNF family of ATP-dependent chromatin remodelers is evolutionarily conserved 
in eukaryotes from yeast to humans. SWI/SNF complexes have critical roles in controlling 
stem cell self-renewal, cellular differentiation, and the basic processes of gene expression, 
DNA replication, repair and recombination (Bartholomew, 2014; Clapier and Cairns, 2009). 
The key enzymatic activities of SWI/SNF are nucleosome mobilization and disassembly. 
Alterations in different subunits of SWI/SNF, as uncovered by genomic sequencing, have 
been linked to cancer and neurological diseases (Kadoch and Crabtree, 2015; Shain and 
Pollack, 2013; Wilson and Roberts, 2011). In many of these instances loss of a subunit 
creates an aberrant form of the SWI/SNF complex that is responsible for the abnormality, 
but the properties of these aberrant complexes remain unknown. In mammals there are 
potentially over 100 different forms of SWI/SNF that differ in subunit composition, thus 
making it difficult to understand why loss of a particular subunit through mutation results in 
the observed phenotype. In the model organism Saccharomyces cerevisiae, there are only 
two types of SWI/SNF that differ in their catalytic and accessory subunits with a small set of 
shared subunits. The simplicity of this system makes it easier to understand the molecular 
defects due to loss of a particular subunit.
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The first subunit of SWI/SNF shown to be a tumor suppressor was SNF5 (SMARCB1 / 
INI1) (Biegel et al., 2002; Sevenet et al., 1999; Versteege et al., 1998). Since then at least six 
other subunits of SWI/SNF were found in different cancers to be mutated (Helming et al., 
2014; Shain and Pollack, 2013). Loss of hSnf5 is a driver mutation in pediatric rhabdoid 
tumors and the loss of a single copy of SNF5 or Smarcb1 in mice leads to cancer in 100% of 
the heterozygotes (Roberts et al., 2000; Roberts et al., 2002). In these cases, the loss of Snf5 
is not accompanied by genomic instability or rearrangements, but rather is an epigenetic 
effect that causes changes in gene expression (Hasselblatt et al., 2013; Lawrence et al., 2013; 
Lee et al., 2012). Also, the loss of Snf5 does not eliminate the entire SWI/SNF complex, but 
instead forms an aberrant complex containing the catalytic subunit Brg1 that is required for 
cell viability (Wang et al., 2009). It remains unclear how the loss of Snf5 affects the integrity 
and underlying enzymatic activity of the SWI/SNF complex due to the difficulty of 
SWI/SNF purification from mammalian cells. It has been suggested that the complex 
remains fairly intact and functional since the expression of certain known SWI/SNF target 
genes are unaffected (Doan et al., 2004). A recent study however has called this into 
question as the re-expression of Snf5 alters expression of several SWI/SNF target genes and 
promotes SWI/SNF recruitment to promoters (Kuwahara et al., 2013). Loss of Snf5 has also 
been shown to affect regulation of the sonic hedgehog and WNT/β-catenin pathways as well 
as expression of cyclin D1(Kim and Roberts, 2014). Studies with recombinant proteins have 
suggested that human Snf5 is a vital part of the enzymatic core of SWI/SNF (Phelan et al., 
1999), however studies with yeast SWI/SNF find the enzymatic core consists of only the 
catalytic subunit and two actin related proteins (Yang et al., 2007). Deletion of Snf5 in 
primary human fibroblasts has similar effects on transcription and chromatin organization as 
does loss of Brg1 and points to Snf5 being vital for Brg1 activity. There remains a lack of 
understanding on how loss of Snf5 precisely impacts the enzymatic activity, recruitment and 
composition of SWI/SNF; which is essential for discerning the role of Snf5 in cancer.
The SWI/SNF complex is highly conserved from yeast to humans, and the human orthologs 
of Snf2 fully complement the loss of SNF2 in yeast. We have deleted the SNF5 gene of 
SWI/SNF in yeast to provide important insights into the properties of the aberrant SWI/SNF 
complex formed in its absence. Our data demonstrate that loss of SNF5 leads to the loss of 
additional SWI/SNF components and that the activity of the residual SWI/SNF complex is 
altered relative to the wild type enzyme. These changes in SWI/SNF activity can affect gene 
expression profiles and signaling pathways that are crucial in cancer development.
Results
A Snf5 submodule composed of Swp82 and Taf14 associates with the SWI/SNF complex 
via Snf5
The architecture of the 12 subunit yeast SWI/SNF complex was investigated by mapping 
inter-subunit and inter-domain contacts by crosslinking proximal lysine residues to each 
other using the homo-bifunctional crosslinker bis-sulfosuccinimdyl suberate (BS3). After 
crosslinking the free SWI/SNF complex in solution, the protein complex was proteolyzed 
and crosslinked peptides were fractionated and identified by mass spectrometry. The 
crosslinks were then mapped onto the linear sequences of the SWI/SNF subunits generating 
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a linkage map for the complex (Fig.s EV1–3). We focused on the interactions involving the 
Snf5 subunit of SWI/SNF and found that Snf5 crosslinked to 6 of the 12 subunits of 
SWI/SNF (Fig. 1A). In addition, we deleted SNF5 and determined how SWI/SNF 
composition was affected by performing Snf6 affinity purification followed by SDS-PAGE 
and Sypro Ruby® staining. Besides Snf5, Swp82 and Taf14 were the only other SWI/SNF 
subunits that failed to co-purify with Snf6 (Fig. 1B). The residual complex was shown to be 
very stable by affinity purification with rigorous washes of 500 mM NaCl and to be a single 
complex by native gel shift binding assays (Fig. 1C). Consistent with the loss of Swp82 and 
Taf14 upon deletion of Snf5, the crosslinking-mass spectrometry (CX-MS) data shows that 
Snf5 extensively crosslinked to both of these subunits. The center of the YEATS domain of 
Taf14 is crosslinked to the N- and C-terminal halves of Snf5. The Rsc7 homology domain of 
Swp82 is crosslinked to a region of Snf5 from residues 150 and 174, and another region of 
Swp82 to the C-terminal end of the Snf5 homology domain. The Snf5 submodule of 
SWI/SNF consisting of Snf5, Swp82 and Taf14 appeared to be tethered to SWI/SNF through 
the Snf5 subunit. Deletion of Swp82 did not cause loss of Snf5 or Taf14 from the complex, 
suggesting Swp82 is not required for the association of Snf5 or Taf14 with SWI/SNF (Fig. 
1B). Taf14 is assembled into other chromatin remodelers and transcription factors besides 
SWI/SNF that do not contain Snf5 or Swp82, and cannot therefore mediate the unique 
association of the Snf5 module to SWI/SNF(Hampsey, 1998; Peterson et al., 1998; Zhang et 
al., 2004). Additional deletion analysis has shown that another submodule of SWI/SNF can 
be formed independent of the Snf5 submodule (data not shown) that consists of Snf2, Snf6, 
Arp7/9, Rtt102 and Snf11.
The Snf5 submodule crosslinked extensively to Swi3 (Fig. 1A), a subunit of SWI/SNF 
previously shown to be important for scaffolding and assembling the entire SWI/SNF 
complex (Yang et al., 2007). Most of these crosslinks with Swi3 were localized in or near 
the SWIRM and SANT domains of Swi3. The N-terminus of Snf5 is also extensively 
crosslinked to two regions on either side of the ARID domain of Swi1. The ARID domain is 
found in the ARID1A/1B/2 subunits of mammalian SWI/SNF and these interactions are 
likely conserved. The Taf14 and Snf5 subunits both crosslink Snf6. Not only is Snf5 
required for Swp82 and Taf14 to stably associated with the SWI/SNF complex, homologs of 
which are not found in mammalian SWI/SNF, but Snf5 is also at the interface with several 
other well conserved subunits that have homologs in mammalian SWI/SNF such as the 
ARID1A, ARID1B, ARID2 and BAF155/SMARCC1 subunits.
Snf5 is required for SWI/SNF recruitment by acidic transcription factors
Previous data indicated that the N-terminus of Snf5 and the ARID region of Swi1 are both 
required for binding of SWI/SNF to acidic activation domains such as VP16 and Gcn4, but 
deletion of one of these domains alone was insufficient to disrupt binding (Neely et al., 
2002; Prochasson et al., 2003). These studies focused primarily on GST pull-down assays to 
determine recruitment defects and they did not test the ability of the complex missing these 
domains or the entire Snf5 subunit to be recruited to DNA by these transcription factors. In 
contrast, we investigated the ability of SWI/SNF complexes lacking the entire Snf5 
submodule (Δsnf5), and those lacking only the Swp82 subunit (Δswp82), to bind 
nucleosomes by gel shift assay. Both complexes were able to bind nucleosomes directly 
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(Fig. 1C, E). SWI/SNF recruitment by the transcription factor containing the DNA binding 
domain of Gal4 fused to the activation domain of VP16 (Gal4-VP16) was severely affected 
by loss of Snf5, in contrast to those earlier studies, but not by the loss of Swp82 (Fig. 1D, 
compare lanes 7–8 to 3–4 and lanes 11–12 to 3–4). These data indicate that Snf5 (and 
possibly Taf14) is required for SWI/SNF recruitment to chromatin by acidic transcription 
factors, but not for the complex to directly bind to nucleosomes.
The highly conserved core of Snf5 contacts the surface of the H2A-H2B dimer in 
nucleosomes
In order to better understand the interactions of the Snf5 subunit when SWI/SNF binds 
nucleosomes, we mapped the region of Snf5 that contacts the H2A-H2B dimer at residue 
109 of H2B using histone photocrosslinking. Nucleosomes are constructed with radiolabeled 
photocrosslinkers attached to various histone sites and a radiolabel is transferred to the 
subunit of SWI/SNF that is most proximal to these sites(Dechassa et al., 2008). This 
approach had previously shown that the Snf5 and Snf2 subunits bind near the H2A-H2B 
dimer, close to residue 109 of histone H2B and at a lesser extent to residues 19 and 89 of 
histone H2A and residue 22 of H4, but did not identify the region of Snf5 involved. The 
photocrosslinked Snf5 subunit from wild type SWI/SNF was gel purified and cleaved at 
Asn-Gly bonds with hydroxylamine (Fig. 2). Proteolytic conditions were varied to obtain 
partial and complete digestion (Fig. 2A). Ultimately, the sizes of the radiolabeled proteolytic 
fragments obtained under these different conditions are diagnostic of the location of the 
crosslink (Fig. 2C). Appropriate molecular weight size markers were made by expressing 
different Snf5 constructs representing partial and complete cleavage products using in vitro 
transcription coupled with translation using cell-free extracts and S-35 labeled methionine 
(Fig. 2B). We found that under partial cleavage conditions, two proteolytic products of 55 
and 61 kDa corresponding to C-terminal fragments of Snf5 are formed due to cleavage at 
amino acids 358 or 410 (417). Since smaller fragments of 23 or 40 kDa were not detected, 
the crosslink does not appear to be at either the N- or C-terminal ends of Snf5. More 
extensive digestion with hydroxylamine generated a 32 kDa fragment that corresponds to the 
region from amino acid 410 (417) to 699. These data show that the conserved Snf5 
homology domain of Snf5 binds to the region of the H2A-H2B near residue 109 of H2B 
when SWI/SNF stably binds nucleosomes. Yeast Snf5 is a much larger polypeptide than the 
mammalian Snf5 homolog, and the ~70% of yeast Snf5 that is unique to the yeast complex 
appears not to make the direct contact with the H2A-H2B acidic pocket. Instead the core 
homology region of yeast Snf5 that is in common with human SNF5 contacts histones H2A-
H2B.
Snf5 module promotes binding of the ATPase domain of Snf2 to nucleosomal DNA
Next, we analyzed by photocrosslinking the interactions of the Δsnf5 complex with the 
histone octamer face that is not bound by DNA. We used histone crosslinking to determine 
whether the interactions between Snf2 and the surface of the H2A-H2B dimer were 
diminished in the absence of Snf5. SWI/SNF interactions were probed at five sites across the 
histone octamer face not bound by DNA including H2B109 that was previously identified as 
a critical site for Snf5 interaction (Fig. 3A). There was no reduction in Snf2 crosslinking at 
any of the five sites when Snf5 was deleted (Fig. 3B). The Swi1 subunit was modestly 
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detected proximal to these sites only when Snf5 was absent. Our data are consistent with 
neither Snf5 nor the Snf5 submodule being required for the stable binding of Snf2 to this 
surface of the nucleosome. The overall affinity of the Δsnf5 complex for nucleosomes was 
thus not adversely affected compared to wild type SWI/SNF, probably because the contacts 
with the histone octamer are retained and likely dominate in determining the affinity of 
SWI/SNF for nucleosomes (Fig. 2C, E).
We next determined how loss of Snf5 changes the interactions of SWI/SNF with 
nucleosomal DNA by site-specific DNA photocrosslinking. In this method, a 
phosphorothioate is incorporated into DNA positions near where the ATPase domain of Snf2 
binds and are coupled to an aryl azide (Dechassa et al., 2012; Zofall et al., 2006). We track 
the interactions of Snf2 and its ATPase domain by crosslinking SWI/SNF at these sites. In 
the wild type SWI/SNF complex, Snf2 crosslinks to DNA facing in and away from the 
octamer 17 and 22 nt from the dyad axis, respectively (Fig. 3C–D). Under comparable 
conditions with full binding of the Δsnf5 complex to nucleosomes, Snf2 crosslinking to 
nucleosomal DNA was reduced 2–3 fold and shows a reduction of Snf2 binding to 
nucleosomal DNA in the absence of Snf5 (Fig. 3E). Interestingly, the impaired crosslinking 
of Snf2 in the Δsnf5 complex persisted in the presence a non-hydrolyzable analog of ATP 
(γ-thio ATP) suggesting that this defect was irreconcilable even when ATP bound to the 
complex. At a position farther away from where the ATPase domain binds, 54 nt from the 
dyad axis, there is no difference in the interactions of Snf2 with DNA in the presence or 
absence of Snf5 (Fig. 3E).
Snf5 contacts and regulates the ATPase domain of Snf2
We suspected that the reduced binding of the ATPase domain to nucleosomal DNA would 
reduce the ATPase and remodeling activities of SWI/SNF. To better understand how loss of 
the Snf5 subunit might destabilize the interactions of the ATPase domain with nucleosomal 
DNA we first re-examined the protein-protein crosslinking data described earlier. These 
experiments showed that a region of Snf5 close to the Snf5 homology domain crosslinks to 
the helicase region of the ATPase domain of Snf2 (Fig. 1A). We reinvestigated the 
crosslinking data by focusing on the subunits of SWI/SNF that crosslink to the Snf2 
catalytic subunit and are likely to directly interact. As expected, we found that the Arp7/
Arp9/Rtt102 module crosslinks to the HSA domain as shown previously (Fig. 4 and 
references (Schubert et al., 2013; Szerlong et al., 2008)). The regions of these three proteins 
that crosslinked to HSA correlated well with those regions of Arp7/Arp9/Rtt102 expected to 
interact with HSA based on its crystal structure (Schubert et al., 2013). We also identified 
other subunits not previously known to interact with the HSA domain. The N-terminus of 
Snf6 and a region spanning residues 1051 to 1064 of Swi1 were proximal to the HSA 
domain and crosslinked to HSA. The Snf6 and Swi1 subunits were likely not observed 
previously because they assemble into SWI/SNF independent of any interactions with the 
HSA domain. In addition a region near the SWIRM domain of Swi3 crosslinked near the AT 
hook of Snf2, and a region of Swi1 near the ARID domain crosslinked to the SnAC domain 
of Snf2. These interactions likely also occur in mammalian SWI/SNF given that these 
regions are conserved between the yeast and mammalian SWI/SNF complexes.
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The Snf5 submodule crosslinks primarily to the ATPase domain of Snf2, specifically to the 
helicase domain and to a lesser extent to the DEXD box domain (Fig. 4A and B). The most 
frequent crosslinks are between the region of Snf5 flanking the Snf5 homology domain and 
the helicase domain. The only other subunits that crosslinked to the ATPase domain were 
components of the Snf5 submodule, suggesting that the Snf5 submodule might have a 
unique role in regulating the activity of the ATPase domain through direct interactions. 
Based on the location of the Snf5 crosslinks on the surface of the ATPase domain, Snf5 
doesn’t appear to regulate the ATPase domain by blocking access to the groove where DNA 
binds (Fig. 4B). Additionally, the other subunits in the Snf5 module, Swp82 and Taf14 also 
contacted the ATPase domain further supporting that this module functions cooperatively to 
modulate the activity of SWI/SNF.
The catalytic efficiencies of wild type and Δsnf5 complexes were determined by measuring 
the rate of ATP hydrolysis at different ATP concentrations and 5-fold molar excess of 
mononucleosomes or nucleosomal arrays over SWI/SNF to ensure saturating conditions. 
Under these conditions, the Δsnf5 complex was not as efficient at hydrolyzing ATP as the 
wild type SWI/SNF, consistent with the reduced binding of the helicase domain with 
nucleosomal DNA as previously observed (Fig. 5A–B compared to Fig. 5C–E). The 
Michaelis-Menten kinetic analysis revealed that the affinity for ATP was unchanged, but the 
kcat or catalytic efficiency was reduced 2 to 3 fold depending on the substrate (Table EV3). 
The primary interactions of the Snf5 subunit observed by protein crosslinking and mass 
spectrometry with the helicase domain of the Snf2 subunit are consistent with Snf5 
regulating either the ATPase or DNA translocase activities of SWI/SNF rather than an ability 
to bind ATP. The reduction in activity was not due to any differences in nucleosome affinity 
as saturating amounts of nucleosomes were used. Reduced ATPase activity was also detected 
with free DNA and the Δsnf5 complex, thus showing that the deficiency is not nucleosome 
specific, even though the effect is less pronounced with DNA than with nucleosomes (Fig. 
5C and Table EV3).
Next, we examined the effects of loss of Snf5 on SWI/SNF mobilization of nucleosomes 
mobilization by mapping DNA movement through the nucleosomes. Here, movement was 
tracked using a photoactive reporter attached to the histone octamer 54 bp from the dyad 
axis and DNA is cleaved after crosslinking the histone to DNA. Snapshots are taken at 
different times to view DNA as it moves past this point in the octamer. Nucleosomes were 
complelely bound in the remodeling assays and and ATP (4.4 μM) was limiting in order to 
examine one round of remodeling. The rate at which nucleosomes were moved from their 
starting position, as evidenced by reduction of DNA cleavage at the reference point 0, was 3 
times slower for the Δsnf5 complex than the wild type complex (Fig. 5A–C and Fig. EV5A). 
By measuring the rate of ATP hydrolysis under these remodeling conditions, we found there 
was no significant difference in the rate of ATP hydrolysis between the wild type and Δsnf5 
complexes, and the defect in remodeling was not coupled to ATP hydrolysis (Fig. 6D). Also 
without Snf5 SWI/SNF appears to be less processive as can be seen by the slower rate at 
which longer movements appear in the Δsnf5 complex (Fig. 6A–B and Fig. EV5B–C). 
Together these data are consistent with Snf5 helping to couple ATP hydrolysis to DNA 
movement.
Sen et al. Page 7
Cell Rep. Author manuscript; available in PMC 2018 February 28.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
The in vivo role of Snf5 in regulation of gene expression
We examined changes in gene expression at the whole-genome level by RNA-seq analysis 
with deletion of SNF2, SNF5 or SWP82. The RNA-seq data was analyzed by filtering for 
only the significant changes in expression observed from the wild type to mutant strains that 
were 2 fold or greater, p value of <0.05 and were reproducible in biological replicates (Fig. 7 
and EV6). The similarities are most striking between wild type and Δswp82 and between 
Δsnf2 and Δsnf5. These data suggest in most instances, except for a small subset of genes, 
Swp82 is not important for regulation by SWI/SNF, and similarly Snf5 is important for the 
majority of SWI/SNF regulated genes. The similarity between Δsnf2 and Δsnf5 could be due 
to the absence of the complex being equivalent to no SWI/SNF recruitment or the reduction 
in SWI/SNF activity caused by loss of Snf5. It is therefore noteworthy that there are 
differences between Δsnf2 and Δsnf5, which suggests the absence of SWI/SNF or its 
catalytic subunit is not completely equivalent to that when Snf5 is absent.
Differences between the Δsnf2 and Δsnf5 strains might be expected if without Snf5 
SWI/SNF is still recruited to a subset of SWI/SNF targets, for example SWI/SNF 
recruitment via histone acetylation at select promoters (Chatterjee et al., 2011; Hassan et al., 
2002; Mitra et al., 2006). Recent work from Jerry Workman and colleagues has shown that 
loss of Snf5 alters but does not eliminate recruitment of the remaining SWI/SNF complex 
formed in its absence (manuscript currently under review). The aberrant complex formed 
and recruited in the absence of Snf5 might function like a dominant negative mutation by 
blocking sites from other chromatin remodelers while still being non-functional, or by 
altering chromatin nonetheless to a lesser extent due to its reduced remodeling activity. The 
genes in cluster 3 appeared to be repressed by SWI/SNF and were activated when Snf2 is 
absent (Fig.7). The effects of loss of Snf5 on the genes in cluster 3 were not as activating as 
the loss of Snf2 possibly because the aberrant Δsnf5 recruited to these sites still remodels 
chromatin, but to a lesser extent. Cluster 2 of Figure 7 shows the loss of Snf5 to be more 
repressive than the loss of Snf2 where wild type SWI/SNF appears to be activating 
transcription. In this case the defective SWI/SNF complex could still be recruited and block 
binding of other remodelers that would otherwise compensate for the loss of SWI/SNF. 
These differences suggest that in addition to being defective for transcription factor mediated 
recruitment there may be cases in which the Δsnf5 complex is properly recruited, but 
because of the reduced remodeling activity is distinct from that when the complex is 
completely absent. GO term analysis of the genes with significantly altered expression when 
Snf5 is deleted shows that loss of Snf5 preferentially down regulates genes involved in DNA 
integration and recombination, and up regulates genes involved in a variety of metabolic 
processes (Table EV4 and EV5). These types of changes in gene expression could be 
consistent with the observed role of Snf5 as a tumor suppressor in rhabdoid tumors.
Discussion
Our results show the modular organization of the SWI/SNF complex and the effects of loss 
of the Snf5 subunit on the properties of yeast SWI/SNF including subunit composition, 
recruitment by acidic transcription factors, ATPase and nucleosome remodeling activities 
and gene expression. The aberrant SWI/SNF complex formed in the absence of Snf5 has 
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several critical differences from the wild type enzyme. First, the subunit composition of 
SWI/SNF is affected by more than just the loss of Snf5 per se as Snf5 associates with several 
other subunits and is key in stabilizing the association of the Swp82 and Taf14 subunits with 
the complex. Although the role of the Swp82 subunit is less clear in the SWI/SNF complex, 
its homolog Rsc7 has been shown to form a critical module with Rsc3, Rsc30 and Htl1 of 
the RSC complex, a paralog of SWI/SNF, and loss of Rsc7 causes increased sensitivity to 
DNA damage and cell stress (Wilson et al., 2006). Taf14 is a protein shared by several 
chromatin remodeling factors such as NuA3, INO80, TFIID and TFIIF complexes. At the N 
terminus of Taf14 is the YEATS domain that binds to acetylated or crotonylated lysine 9 of 
histone H3 (H3K9ac or H3K9cr). Taf14 is important for gene transcription and DNA 
damage repair (Andrews et al., 2016; Shanle et al., 2015; Zhang et al., 2011). Although 
homologs of Swp82 and Taf14 are not found in mammalian SWI/SNF, other subunits are 
likely to be lost in human SWI/SNF due to the extensive bridging activity of Snf5 observed 
in the yeast SWI/SNF complex.
The Snf5 module also serves two important roles in SWI/SNF recruitment by facilitating in 
recognition of active histone marks (H3K9ac and H3K9cr) and recognition by particular 
transcription factors. Earlier data found the N-terminus of Snf5 and a portion of Swi1 
together are required for SWI/SNF recruitment by particular transcription factors (Ferreira et 
al., 2009; Prochasson et al., 2003). In these studies loss of the N terminus of Snf5 alone was 
insufficient and did not have a strong effect on recruitment. Our data suggest that other parts 
of Snf5 may also contribute to recruitment as the loss of Snf5 alone and not Swp82 blocked 
recruitment by a transcription factor containing the VP16 acidic activation domain. In the 
absence of Snf5, SWI/SNF retains its affinity for nucleosomes and the potential for the 
Δsnf5 complex being recruited by other mechanisms to some of the SWI/SNF normal 
targets. ChIP-seq data from the laboratory of Jerry Workman shows that the Δsnf5 complex 
is recruited to some but not all of the SWI/SNF targets, consistent with our results (in this 
same issue).
There have been discrepancies as to what constitutes the minimal enzymatic core of the 
SWI/SNF complex. Some have suggested the Snf2 catalytic subunit with the Arp7 and Arp9 
subunits can account for 90% of the enzymatic activity of the entire SWI/SNF complex 
(Yang et al., 2007). In other experiments with mammalian SWI/SNF, reconstitution with 
recombinant subunits has suggested the minimal core complex includes Snf5, Brg1 
(homolog of Snf2) and BAF155/170 (homologs of Swi3) (Phelan et al., 1999). Although the 
differences between these two studies could be partially reconciled due to differences 
between the yeast and human SWI/SNF complexes, our results show that Snf5 is a vital part 
of the enzymatic core of the yeast SWI/SNF complex much like that shown for the human 
SWI/SNF complex. Our approach is different than those previously, because we did not 
attempt to show the role of Snf5 by trying to reconstitute the core enzyme with recombinant 
proteins. Instead we took a three-pronged approach, first showing the effects of loss of Snf5 
on the activity of SWI/SNF in terms of ATPase activity and DNA movement inside of 
nucleosomes. Second, we provide evidence that Snf5 directly contacts the helicase lobe of 
Snf2 and can therefore directly regulate the activity of Snf2. And third, the loss of enzymatic 
activity is associated with reduced binding of the ATPase domain of Snf2 to nucleosomal 
DNA as shown by mapping SWI/SNF interactions with DNA crosslinking. In other 
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experiments with cryo-electron microscopy, SWI/SNF is observed to bind nucleosomes in a 
pincer manner with one side of the pincer consisting of Snf5 and the ATPase domain of 
Snf2, consistent with the vital role of Snf5 in the enzymatic activity of SWI/SNF 
(manuscript in preparation).
We confirm the importance of the Snf5 subunit for the in vivo activity of SWI/SNF and the 
validity of our biochemical analysis by RNA-seq. We find that loss of Snf5 affects many of 
the same targets as loss of the Snf2 catalytic subunit, but nonetheless are not identical. These 
results mirror much of the same effects seen when BRG1 or SNF5 are separately knocked 
out in primary human fibroblasts and suggests that we may be examining effects in yeast 
that are similar to that when Snf5 is absent in humans (Tolstorukov et al., 2013). In some 
instances loss of Snf5 in yeast has a more severe effect than the loss of the complex caused 
by deletion of SNF2, consistent with the aberrant, less active complex being recruited to 
these sites and having a more pronounced effect than its mere absence. These effects are 
suggested to depend on the genomic landscape of the targets as not all targets behave in this 
manner. In summary, we have shown that the loss of a single subunit such as Snf5 from 
SWI/SNF can have pleiotropic effects on SWI/SNF, thereby affecting its subunit 
composition, recruitment to chromatin, and enzymatic activities; making truly an altered 
form of the complex.
Experimental Procedures
Purification of SWI/SNF complexes
SWI/SNF complexes with FLAG tagged subunits were purified by immunoaffinity 
chromatography using anti-FLAG M2 agarose beads (Dechassa et al., 2008). The activities 
of the purified complexes were tested with binding, remodeling and ATPase assays (Sen et 
al., 2013). Different preparations of the Δsnf5 complex were purified and compared to 
ensure a lack of variation in enzymatic activity between preparations.
Nucleosome reconstitution and gel shift assays for binding and recruitment by Gal4-VP16
Mononucleosomes were reconstituted with 5.2 μg of PCR-generated 29N59 DNA (29 and 
59 bp of flanking DNA on either side of 601), 100 fmol 32P-labeled 29N59 DNA, and 9 μg 
wild-type Xenopus laevis refolded octamer at 37°C by a rapid salt dilution method.
For standard binding gel shift assays, SWI/SNF (1.6 to 26 nM in two-fold increments) was 
titrated into binding reactions containing 6.4 nM radiolabeled mononucleosomal templates 
in 20mM Na HEPES, 3mM MgCl2, 0.08% NP40, 1.7% glycerol, 60mM NaCl and 200uM 
PMSF at 30°C for 30 minutes. For recruitment assays, 4.3 nM Gal4-VP16 was bound to 6.4 
nM radiolabeled mononucleosomes in presence of 25 ng sonicated salmon sperm competitor 
DNA for 30 minutes at 30°C. SWI/SNF (13 or 26 nM) was added and incubated at 30°C for 
30 minutes. The bound products were resolved on a 4% native polyacrylamide gel 
(acrylamide:bisacrylamide 79:1) in 0.5X TBE at 4°C and visualized by autoradiography.
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ATPase assays
ATPase assays were performed under conditions identical to the remodeling time-course 
assays (see section on Site-directed mapping) with 0.055 μCi [γ-32P]ATP in a 13.5 μl 
reaction volume. Reactions were terminated by addition of EDTA and SDS to a final 
concentration of 37.5 mM and 2% respectively. Reactions were spotted onto a 
polyethyleneimine cellulose plate (J.T. Baker) and developed with 0.5 M LiCl and 0.5 M 
formic acid.
Michaelis-Menten kinetics
ATPase assays were performed under multiple turnover conditions with excess nucleosomes 
(mononucleosomes or 200–12 nucleosomal arrays or DNA) compared to SWI/SNF complex 
(5:1 molar ratio). ATP concentration was varied from 2–600 μM and non-linear regression 
analysis of the velocity vs. ATP concentration curves was used to estimate Km and kcat.
DNA-photoaffinity labeling
DNA photoaffinity labeling was performed as described under normal binding conditions 
(Dechassa et al., 2012). Relative crosslinking was estimated by normalizing the Snf2 band 
intensity at all positions to the intensity at the-17 position.
Histone cross-linking and label transfer
Histone crosslinking and label transfer was performed as described with the crosslinked 
products resolved on a 4–20% SDS PAGE and visualized by autoradiography (Dechassa et 
al., 2008). The intensity of the cross-linked Snf2 band across all samples was quantified 
relative to the intensity at the H380 position in the WT SWI/SNF complex.
RNA-seq analysis
Yeast strains (wild type and mutants) in the BY4741 background were grown to an OD600 
of approximately 0.75 – 1.0 in three independent biological replicates. Total RNA was 
extracted using the hot acid phenol method (Collart and Oliviero, 2001). Samples were 
phenol/chloroform extracted and ethanol precipitated before resuspension in 50 μl of 
diethylpyrocarbonate treated water. After checking the quality of RNA using an Agilent 
bioanalyzer 2100, a library was prepared using Truseq Stranded mRNA LT Sample 
Preparation kit (Illumina, RS-122-2101/2102). Initial extension steps of cluster generation 
were performed on cBot (Illumina, San Diego, CA) using TruSeq Rapid Duo cBot Sample 
Loading Kit (Illumina) followed by additional cluster generation steps and 76 bp paired end 
sequencing using an Illumina HiSeq 2500 platform on rapid run mode. Fragments were 
mapped to the yeast reference genome sacCer3, using TopHat V2.0.10 and Bowtie V2.1.0. 
Differential gene expression analysis was performed using EdgeR 3.8.6. Data was filtered 
using fold change >=2 and p < 0.05. The expression values were log transformed and 
normalized (mean of 0 and standard deviation of 1) using Cluster V 3.0 and grouped by k-
Means clustering (6 clusters). Heat maps were generated using Java TreeView V 1.1.6r4. 
Gene Ontology (GO) enrichment analysis was performed using GORILLA (Eden and 
Navon, 2009).
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Site-directed mapping
Histone octamers containing cysteine at residue 53 of H2B were conjugated to p-azido 
phenacyl bromide (APB) immediately after the octamer refolding process. Site-directed 
histone-DNA crosslinking was performed as described previously (Kassabov and 
Bartholomew, 2004). Nucleosomes were bound with saturating amount of SWI/SNF at 
30°C. Nucleosome mobilization was performed using 4.4 μM ATP at 25°C and stopped with 
excess EDTA (15mM). Lane intensities were normalized for loading bias using Microsoft 
Excel. Normalized band intensities were plotted as a function of time and fitted into single 
phase exponential equation using GraphPad (PRISM Version 6.0b). Overlays for different 
time points were made using the ggplot2 package in R.
Peptide mapping
Wild type SWI/SNF was bound to nucleosomes that had been labeled at residue 109 of 
histone H2B with 125I-PEAS as described previously (Dechassa et al., 2008). After 
photocrosslinking, the subunits were separated on a 6% SDS-PAGE and the crosslinked Snf5 
was visualized by phosphorimaging. Radiolabeled Snf5 was excised from the gel and 
isolated by electroelution with 50 mM NH4HCO3 and 0.1% SDS (Dechassa et al., 2012). 
Markers of the proteolytic fragments of Snf5 were made using an in vitro coupled rabbit 
reticulocyte lysate transcription-translation system from Promega. DNA encoding the 
different fragments of Snf5 were constructed to contain an upstream T7 promoter and a 
downstream T7 terminator by PCR amplification of the desired region of Snf5.
Crosslinking and mass spectrometry analysis
SWI/SNF was purified using a Snf2 FLAG-tagged strain as described previously (Kapoor et 
al., 2015). The complex was further purified over an SP Sepharose column to remove FLAG 
peptide before crosslinking with BS3 (Thermo Scientific). BS3 was added to 500 μl of 
purified SWI/SNF (174 fmol/μl) to a final concentration of 2 mM or 5 mM. After 2 hours at 
RT, the reactions were quenched by addition of 20 μl 1M ammonium bicarbonate, and the 
proteins were precipitated by addition of TCA to 16.7%. Proteins were resuspended in 100 
μl 8 M urea in 2 M ammonium bicarbonate prior to reduction with 10 mM TCEP (tris(2-
carboxyethyl)phosphine), and alkylation with 20 mM iodoacetamide. The urea concentration 
was reduced to 1 M by addition of 100 mM ammonium bicarbonate and trypsin was added 
at a 20:1 (weight:weight) ratio) for an overnight incubation at 37°C. The resulting peptides 
were desalted on a C18 column and then fractionated by microcapillary strong cation 
exchange chromatography (200 μm I.D. X 20 cm). Peptides were loaded onto the column 
and washed with Buffer A [20% acetonitrile (ACN), 0.1% formic acid (FA)]. Peptides were 
eluted in 4 steps by increasing the percentage of Buffer B (20% ACN, 1.0 M ammonium 
formate, pH 3.5): 30% B, 50% B, 70% B and 100%B. A final elution with 10% ACN, 500 
mM ammonium acetate was also used. Each fraction was dried and analyzed directly by 
mass spectrometry.
Peptides were analyzed on a Thermo Scientific Orbitrap Elite with HCD fragmentation and 
serial MS events that included one FTMS1 event at 30,000 resolution followed by 10 
FTMS2 events at 15,000 resolution. Other mass spectrometry settings include: charge state 
rejection enabled, unassigned reject, charge state 1+, 2+ and 3+ rejected, 4+ and over not 
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rejected; HCD isolation window 3Da, normalize energy 35%; MS mass range: 1500–
1000000, use m/z value as masses enabled; FTMS MSn AGC target 5e5, FTMS MSn max 
ion time 300 ms. An 80 min gradient from 5% ACN, 0.1% FA to 40% ACN, 0.1% FA was 
used for reverse phase chromatography.
The RAW files were converted to mzXML files. We used the Comet search engine and the 
Trans-Proteomic Pipline (TPP, http://tools.proteomecenter.org/wiki/index.php?
title=Software:TPP) for the identification of unmodified and BS3 mono-modified 
(monolinks) peptides. For crosslinked peptide searches, we used two different database 
search algorithms: pLink (Yang et al., 2012) and our in-house designed Nexus with default 
settings (Knutson et al., 2014) to search a protein database containing the sequences of the 
12 SWI/SNF subunits and their reverse decoy sequences. A 5% false discovery rate (FDR) 
was used for both pLink and Nexus searches. After performing the pLink and Nexus 
searches, the results were combined and each spectrum was manually evaluated for the 
quality of the match to each peptide using the COMET/Lorikeet Spectrum Viewer (TPP). 
Crosslinked peptides were considered confidently identified if at least 4 consecutive b or y 
ions for each peptide were observed and the majority of the observed ions are accounted for. 
Twenty intralinked spectra, out of total 3561 spectra (0.56%), corresponding to 20 
intralinked peptides, and 151 interlinked spectra, out of total 1781 (8.5%), corresponding to 
130 interlinked peptides were removed due to poor spectral support.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Transcription defects due to the loss of Snf5 are not the same as the loss of 
SWI/SNF
• Snf5 has a scaffolding role and is required for TAF14 and Swp82 to be in 
SWI/SNF
• Snf5 interacts with the ATPase domain of Snf2 and promotes its binding to 
DNA
• Snf5 is essential for SWI/SNF recruitment by the Gal4-VP16 transcription 
factor
Sen et al. Page 17
Cell Rep. Author manuscript; available in PMC 2018 February 28.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. Interactions of the Snf5 module in SWI/SNF
(A) The interactions of Snf5 with other subunits in the SWI/SNF complex were determined 
by crosslinking with the homo-bifunctional, lysine-specific crosslinker BS3 and subsequent 
analysis by mass spectrometry. The SWI/SNF subunits shown are Snf2 (brown), Swi1 
(purple), Swi3 (orange), Swp82 (blue), Snf6 (magenta) and Taf14 (green). Lysine residues 
are indicated by green circles and the labeled boxes are the conserved domains. Only those 
interactions in which 2 or more crosslinks were detected in a region spanning ~30 amino 
acids are shown and the number of crosslinks detected are indicated by the circled numbers. 
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The thickness of the black line is also indicative of the number of crosslinks detected in that 
region. (B) SWI/SNF complexes were purified by immuno-affinity chromatography with 
either Snf5 or Swp82 deleted and analyzed on a 4–20% SDS polyacrylamide gel. Wild type 
SWI/SNF (lane 3) contains two FLAG tags at the C-terminus of Snf2. Snf6 was tagged with 
a double FLAG tag at its C terminus in the Δsnf5 (lane 2) and Δswp82 (lane 1) SWI/SNF 
complexes. (C) Recruitment of wild type and mutant SWI/SNF by the acidic transcription 
activator Gal4-VP16 was tracked by gel shift analysis. Nucleosomes alone (N), nucleosomes 
bound by Gal4-VP-16 (N-Gal4) and nucleosomes bound by SWI/SNF with or without Gal4-
VP16 (N-Gal4-SWI) migrated at the indicated positions. Gal4-VP16 was added to lanes 2, 
4, 7, 8, 11, and 12. Wild type, Δsnf5 and Δswp82 SWI/SNF were add in lanes 3–4, 5–8, and 
9–12, respectively. (D) Purified SWI/SNF complexes from wild type (WT) and mutant yeast 
strains (as indicated) were added to nucleosomes reconstituted with radiolabeled 601 DNA 
and Xenopus laevis histone octamers and resolved on a 4% native polyacrylamide gels. Free 
nucleosomes are labeled N and nucleosomes bound by SWI/SNF as N-SWI. (E) The amount 
of bound nucleosomes versus SWI/SNF was determined from gel shift assays as shown in 
(B) and plotted. The estimated KD for wild type, Δsnf5 and Δswp82 SWI/SNF were 102 
± 19, 101 ± 15 and 82 ± 21 nM (standard deviation from mean), respectively, and were from 
three technical replicates.
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Figure 2. The highly conserved core domain of the Snf5 subunit contacts nucleosomes near the 
exposed surface of the histones H2A-H2B
(A) SWI/SNF was recruited to nucleosomes by Gal4-VP16 in presence of competitor DNA 
to ensure specific SWI/SNF interaction with nucleosomes. After photocrosslinking the 
labeled Snf5 was isolated and cleaved at Asn-Gly positions with hydroxylamine. The 
cleaved products were resolved by SDS-PAGE and visualized by phosphorimaging to 
determine the crosslinked sites using Snf5 marker polypeptides described in section. (B) 
Four different regions of Snf5 were prepared by in vitro coupled transcription-translation in 
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presence of S-35 methionine. The numbers on the top show the regions of Snf5. (C) The 
domain organization of Snf5 and the locations of the Asn-Gly cleavage sites are shown. The 
expected hydroxylamine partial and complete cleavage products are shown.
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Figure 3. The catalytic subunit does not make stable contact with nucleosomal DNA in the 
absence of the Snf5 module, but does with the histone octamer surface
(A) The interactions of wild type (WT) and Δsnf5 SWI/SNF with nucleosomes were mapped 
by histone photocrosslinking with photoreactive radio-iodinated N-((2-
pyridyldithio)ethyl)-4-azidosalicylamide (PEAS) attached to specific histone positions as 
indicated by histone type and residue position. (B) The relative crosslinking efficiency of 
Snf2, Snf5, Swi3 and in some instances Swi1 was plotted for each of the five histone 
positions and for WT and Δsnf5 SWI/SNF. Signals were normalized relative to crosslinking 
in WT SWI/SNF to residue 80 of histone H3 (H380). (C–D) Purified WT SWI/SNF 
complex was bound to nucleosomes reconstituted with radiolabeled DNA probes containing 
photoreactive groups at the positions indicated (“0” corresponding to the dyad). Reactions 
contained either wild type (lanes 1–3) or Δsnf5 (lanes 4–6) complexes. In some instances 
150 μM γ-thio-ATP (lanes 2 and 5) or 13 μg/ml competitor DNA (lanes 3 and 6) were 
added. (E) The efficiency of Snf2 crosslinking to DNA was plotted for four different 
positions within nucleosomal DNA and were normalized to nt-17. These experiments were 
done in triplicates and the standard deviation (SD) is shown.
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Figure 4. Snf5 contacts the ATPase domain of the catalytic subunit
(A) The interactions of Snf2 with other SWI/SNF subunits were examined in the same 
manner as described for Snf5 in Figure 3. Besides the known interactions of the Arp7, Arp9 
and Rtt102 module there also are interactions of the Snf5, Swp82 and Taf14 module with 
Snf5. Only those crosslinks in which 2 or more crosslinks were detected in a region 
spanning ~30 amino acids are shown. The total number of crosslinks detected is indicated by 
the circled number. (B) The ATPase domain of Snf2 bound to DNA was modeled based on 
the sequence similarity with the ATPase domain of RAD54 (Dechassa et al., 2012). The 
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lysine residues crosslinked to the Snf5 subunit are indicated as blue space filling residues 
and are primarily in the HELIC lobe of the ATPase domain. Domains are color coded as 
indicated in the schematic at the bottom of the figure.
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Figure 5. Snf5 regulates the catalytic activity of the ATPase domain of SWI/SNF
The rate of ATP hydrolysis (V) was determined at different concentrations of ATP and 
plotted as a function of ATP concentration. KM and kcat values were obtained by fitting data 
to the Michaelis-Menten equation using GraphPad (PRISM Version 6.0b). Concentrations of 
substrates and enzymes were (A) 8 nM nucleosomal array (12 repeats of 200bp), 1.6 nM 
enzyme (WT/Δsnf5) and 2–600 μM ATP; (B) 8 nM 29N59 nucleosome, 1.6 nM enzyme, 
and 2–300 μM ATP; and (C) 50 nM 100 bp DNA, 10 nM enzyme, and 10–300 μM ATP. 
Error bars and reported values are mean ± SE from three technical replicates.
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Figure 6. Loss of the Snf5 subunit adversely affects the intrinsic nucleosome mobilizing activity 
of SWI/SNF
(A–B) Nucleosomes modified at residue 53 of histone H2B were used for monitoring 
movement of DNA on the octamer surface. DNA cleavage products were resolved on a 
denaturing 6% polyacrylamide gel and visualized by phosphorimaging. Numbers on the 
right side of the gel image refer to number of nucleotides (nt) moved from the starting 
cleavage position (0). Nucleosomes were remodeled with WT (A), and Δsnf5 SWI/SNF (B) 
for 0, 5, 10, 20, 30, 40, 50, 60, 70, 80 and 160 s using 4.4 μM ATP. (C) The amount of DNA 
cleaved at starting position (0) was plotted versus time for WT SWI/SNF and Δsnf5 SWI/
SNF. Rate constants (k) obtained by fitting data to single exponential function were 
0.044± 0.004 s−1 (WT) and 0.016 ± 0.005 s−1 (Δsnf5). Bars and reported values are the 
mean ± SE from two replicates. (D) ATPase assays were performed in the same conditions 
as (A and B) and the released radioactive phosphate (Pi) was separated from non-hydrolyzed 
ATP by thin layer chromatography (TLC). The percentage Pi released is plotted as a 
function of time. ATP hydrolysis rates obtained were 0.9 μM s−1 (WT) and 0.7 μM s−1 
(Δsnf5).
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Figure 7. In vivo targets affected by loss of Snf5 both overlap and are distinct from that of Snf2
(A) RNA-seq heat map depicts those genes with fold change >= 2 in expression (506) and 
satisfy the parameters of a p < 0.05. Genes were grouped into 6 clusters using k-Means 
clustering. A total of 5,935 genes were analyzed.
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